pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 8,127 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
Ketalar
Ketalar (ketamine hydrochloride)
General Anesthetic Effect
Par Pharmaceutical Inc
3 catalysts
Marketed
LOPERAMIDE HYDROCHLORIDE
LOPERAMIDE HYDROCHLORIDE (LOPERAMIDE HYDROCHLORIDE)
Diarrhea
LNK International Inc (Inactive)
3 catalysts
Marketed
NEOSTIGMINE METHYLSULFATE
NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)
Acetylcholinesterase
$AMPHAmphastar Pharmaceuticals, Inc.
catalysts
← prev
page 14 of 271
next →
131
Pain89
Neurology1
3
Marketed
OSENVELT
OSENVELT (DENOSUMAB-BMWO)
Celltrion Inc
3 catalysts
Marketed
PROGESTERONE
PROGESTERONE (PROGESTERONE)
Female Infertility
Progesterone receptor
IBSA Institut Biochimique SA
3 catalysts
Marketed
PRUCALOPRIDE SUCCINATE
PRUCALOPRIDE SUCCINATE (PRUCALOPRIDE SUCCINATE)
Constipation
SpecGx LLC
3 catalysts
Marketed
ROCURONIUM BROMIDE
ROCURONIUM BROMIDE (ROCURONIUM BROMIDE)
Muscle Relaxation
Piramal Critical Care Inc
3 catalysts
Marketed
SITAGLIPTIN PHOSPHATE
SITAGLIPTIN PHOSPHATE (SITAGLIPTIN PHOSPHATE)
Type 2 Diabetes
Merck Sharp & Dohme LLC
3 catalysts
Marketed
SODIUM ACETATE
SODIUM ACETATE (SODIUM ACETATE)
$AMRXAmneal Pharmaceuticals, Inc.
3 catalysts
Marketed
SODIUM BICARBONATE
SODIUM BICARBONATE (SODIUM BICARBONATE)
$AMRXAmneal Pharmaceuticals, Inc.
3 catalysts
Marketed
SODIUM PHENYLBUTYRATE
SODIUM PHENYLBUTYRATE (SODIUM PHENYLBUTYRATE)
Carbamoyl-Phosphate Synthase I Deficiency
Horizon Therapeutics USA Inc
3 catalysts
Marketed
URSODIOL
URSODIOL (URSODIOL)
Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
RK Pharma Inc
3 catalysts
Marketed
VARENICLINE TARTRATE
VARENICLINE TARTRATE (VARENICLINE TARTRATE)
Keratoconjunctivitis Sicca (Dry Eye)
Oyster Point Pharma Inc
3 catalysts
adebrelimab
Jiangsu Hengrui Pharmaceuticals Co Ltd
3 catalysts
Marketed
aflibercept biosimilar
Ahzantive (aflibercept-abzv)
Diabetic Macular Edema
Placenta growth factorVascular endothelial growth factor A, long form
Sam Chun Dang Pharm Co Ltd
3 catalysts
Marketed
avacincaptad pegol sodium
Izervay (avacincaptad pegol sodium)
Geographic Atrophy
Astellas Pharma US Inc
3 catalysts
Marketed
capecitabine
Capecitabine (capecitabine)
Colon Cancer
Armas Pharmaceuticals Inc
3 catalysts
Marketed
cyclophosphamide
Cyclophosphamide (cyclophosphamide [INN])
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Long Grove Pharmaceuticals LLC
3 catalysts
Marketed
dalfampridine ER
Dalfampridine Mylan (dalfampridine)
Hypokinesia
Mylan Pharmaceuticals Inc
3 catalysts
Marketed
ensartinib hydrochloride
Ensacove (ensartinib hydrochloride)
Non-Small Cell Lung Cancer
Xcovery Holdings Inc
3 catalysts
Marketed
evinacumab
Evkeeza (evinacumab-dgnb)
Homozygous Familial Hypercholesterolemia (HoFH)
$REGNREGENERON PHARMACEUTICALS, INC.
3 catalysts
Marketed
futibatinib
Lytgobi (futibatinib)
Bile Duct Cancer (Cholangiocarcinoma)
Fibroblast growth factor receptor
Taiho Oncology Inc
3 catalysts
Marketed
glofitamab
Columvi (glofitamab-gxbm)
Mantle Cell Lymphoma
B-lymphocyte antigen CD20T cell surface glycoprotein CD3
F. Hoffmann-La Roche Ltd
3 catalysts
Marketed
granisetron ER
Sustol (granisetron)
Chemotherapy Induced Nausea and Vomiting
Heron Therapeutics Inc
3 catalysts
Marketed
inavolisib
Itovebi (inavolisib)
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
F. Hoffmann-La Roche Ltd
3 catalysts
Marketed
lazertinib mesylate
Lazcluze (lazertinib mesylate)
Non-Small Cell Lung Cancer
Epidermal growth factor receptor
$JNJJOHNSON & JOHNSON
3 catalysts
Marketed
lebrikizumab
Ebglyss (lebrikizumab)
Atopic Dermatitis (Atopic Eczema)
Lilly USA LLC
3 catalysts
levobupivacaine
Swami Dayanand Hospital
3 catalysts
Marketed
marstacimab
Hympavzi (marstacimab-hncq)
Hemophilia A (Factor VIII Deficiency)
Tissue factor pathway inhibitor
$PFEPFIZER INC
3 catalysts
Marketed
mirabegron ER
Myrbetriq (mirabegron)
Neurogenic Bladder Dysfunction
Astellas Pharma US Inc
3 catalysts